Researchers identified 30 genes in the nasal passages of patients with lung cancer that were active in a different way from those in people without the disease.
This nasal swab could someday be used to confirm the disease after patients have a CT scan, thus avoiding unnecessary follow-up procedures and lung biopsies.
Source: Bottom Line Personal May 2017 Marc Lenburg, PhD, associate professor of medicine, Boston University, and coauthor of a study published in Journal of the National Cancer Institute.
PLEASE REMEMBER TO DONATE THANK YOU!